Redhill Biopharma Ltd (NASDAQ:RDHL)

7.02
Delayed Data
As of Apr 12
 -0.31 / -4.24%
Today’s Change
5.93
Today|||52-Week Range
11.52
-13.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues3.0K101.3K4.0M8.3M
 
 
 
 
 
Cost of Goods Sold0.00--2.1M2.7M
 
 
 
Depreciation And Amortization36.0K44.1K81.6K89.7K
 
 
 
 
 
 
Operating ExpensesGross Income-33.0K--1.9M5.5M
 
 
 
 
General Expenses21.9M30.7M53.4M44.7M
 
 
 
 
 
Research And Development17.8M25.3M33.2M24.8M
 
 
 
 
 
Total Operating Expenses21.9M30.7M55.5M47.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.9M-30.6M-51.5M-39.2M
 
 
 
 
 
Extraordinary Credit887.7K1.2M5.7M397.7K
 
 
 
 
 
Extraordinary Charge-100.0K-369.2K-851.0K--
 
 
 
 
Other Expenses-211.9K27.1K447.2K-166.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-21.1M-29.5M-45.9M-38.7M
 
 
 
 
 
Net Income-21.1M-29.5M-45.9M-38.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.1M12.9M17.7M23.1M
 
 
 
 
 
Shares To Calculate EPS Diluted11.2M12.9M17.7M23.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.90-$2.31-$2.62-$1.67
 
 
 
 
 
EPS Diluted-$1.90-$2.41-$2.62-$1.67